Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits From Trastuzumab

Case Reports in Oncological Medicine - Egypt
doi 10.1155/2020/9072173
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Hindawi Limited

Related search

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling

Scientific Reports
Multidisciplinary
2014English

Author Correction: Comprehensive Molecular Profiling of Lung Adenocarcinoma

Nature
Multidisciplinary
2018English

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing

PLoS ONE
Multidisciplinary
2016English

Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma

Oncology
MedicineCancer ResearchOncology
2016English

Disseminated Intravascular Coagulation in a Patient With Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Preexisting Oncogenic Events Impact Trastuzumab Sensitivity in ERBB2-amplified Gastroesophageal Adenocarcinoma

Journal of Clinical Investigation
Medicine
2014English

MA16.05 MET Kinase Domain Rearrangements (KDRE) in Non-Small Cell Lung Cancer (NSCLC) Identified Through Comprehensive Genomic Profiling (CGP)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

HER2/neu (ERBB2) Expression and Gene Amplification Correlates With Better Survival in Esophageal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy